Literature DB >> 9880084

Cloning and characterization of the human galanin GALR2 receptor.

B Borowsky1, M W Walker, L Y Huang, K A Jones, K E Smith, J Bard, T A Branchek, C Gerald.   

Abstract

We present the molecular cloning and characterization of the human galanin receptor, hGALR2. hGALR2 shares 85%, 39%, and 57% amino acid identities to rGALR2, hGALR1, and hGALR3, respectively. hGALR2, along with rGALR2, can be distinguished from the other cloned galanin receptors by a tolerance for both N-terminal extension and C-terminal deletion of galanin, as well as by a primary signaling mechanism involving phosphatidyl inositol hydrolysis and calcium mobilization. By RT-PCR, GALR2 mRNA was abundant in human hippocampus, hypothalamus, heart, kidney, liver, and small intestine. A weak GALR2 mRNA signal was detected in human retina, and no signal was detected in cerebral cortex, lung, spleen, stomach, or pituitary.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9880084     DOI: 10.1016/s0196-9781(98)00133-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299.

Authors:  Chad J Swanson; Thomas P Blackburn; Xuexiang Zhang; Kang Zheng; Zhi-Qing David Xu; Tomas Hökfelt; Toni D Wolinsky; Michael J Konkel; Heidi Chen; Huailing Zhong; Mary W Walker; Douglas A Craig; Christophe P G Gerald; Theresa A Branchek
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-15       Impact factor: 11.205

Review 2.  Galanin and its receptors in neurological disorders.

Authors:  Linda Lundström; Anna Elmquist; Tamas Bartfai; Ulo Langel
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

3.  GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.

Authors:  Xiaoying Lu; Edward Roberts; Fengcheng Xia; Manuel Sanchez-Alavez; Tianyu Liu; Roger Baldwin; Stephanie Wu; James Chang; Claude G Wasterlain; Tamas Bartfai
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

4.  Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.

Authors:  Charles R Robertson; Erika Adkins Scholl; Timothy H Pruess; Brad R Green; H Steve White; Grzegorz Bulaj
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

5.  Galanin inhibition of voltage-dependent Ca(2+) influx in rat cultured myenteric neurons is mediated by galanin receptor 1.

Authors:  Laura Anselmi; Salvatore L Stella; Nicholas C Brecha; Catia Sternini
Journal:  J Neurosci Res       Date:  2009-04       Impact factor: 4.164

6.  Galanin receptors and ligands.

Authors:  Kristin E B Webling; Johan Runesson; Tamas Bartfai; Ulo Langel
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-07       Impact factor: 5.555

7.  Cardioprotective properties of N-terminal galanin fragment (2-15) in experimental ischemia/reperfusion injury.

Authors:  Oleg Pisarenko; Andrei Timotin; Oksana Kunduzova; Maria Sidorova; Irina Studneva; Valentin Shulzhenko; Marina Palkeeva; Larisa Serebryakova; Aleksander Molokoedov; Oksana Veselova; Mathieu Cinato; Frederic Boal; Helene Tronchere
Journal:  Oncotarget       Date:  2017-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.